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tient psychotherapy.  Methods: The study was conducted 
between March 2003 and June 2008 in 6 mental health care 
centres in the Netherlands, with a sample of 371 patients 
with a DSM-IV-TR axis-II cluster C diagnosis. Patients were as-
signed to 5 different modalities of psychotherapeutic treat-
ment, and effectiveness was assessed at 12 months after 
baseline. An intention-to-treat analysis was conducted for 
psychiatric symptoms (Brief Symptom Inventory), psychoso-
cial functioning (Outcome Questionnaire-45), and quality of 
life (EQ-5D), using multilevel statistical modelling. As the 
study was non-randomised, the propensity score method 
was used to control for initial differences.  Results: Patients 
in all treatment groups had improved on all outcomes 12 
months after baseline. Patients receiving short-term inpa-
tient treatment showed more improvement than patients 
receiving other treatment modalities.  Conclusions: Psycho-
therapeutic treatment, especially in the short-term inpatient 
modality, is an effective treatment for patients with cluster 
C personality disorders.  Copyright © 2009 S. Karger AG, Basel 
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 Abstract 
 Background: No previous studies have compared the effec-
tiveness of different modalities of psychotherapeutic treat-
ment, as defined by different settings and durations, for pa-
tients with cluster C personality disorders. The aim of this 
multicentre study was to compare the effectiveness of 5 
treatment modalities for patients with cluster C personality 
disorders in terms of psychiatric symptoms, psychosocial 
functioning, and quality of life. The following treatment mo-
dalities were compared: long-term outpatient (more than 6 
months), short-term day hospital (up to 6 months), long-
term day hospital, short-term inpatient, and long-term inpa-
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 Introduction 
 An estimated 2.6% of the general population is affect-
ed by cluster C personality disorders (PD): avoidant, de-
pendent, and obsessive-compulsive PD  [1] . This cluster of 
PD is associated with significant functional impairment 
 [2–4] and a high economic burden  [5] , yet studies inves-
tigating treatment effectiveness in this patient population 
are scarce  [6] . As in research on other psychological dis-
orders [e.g.  7 ], the available studies on cluster C PD typi-
cally compare treatments that are identical in treatment 
setting and duration. Investigators have compared differ-
ent outpatient treatments  [8–13] , different day hospital 
treatments  [14, 15] , and different inpatient treatments  [16, 
17] . One recent study in Norway  [18] compared outpa-
tient and day hospital treatment for patients with all 
forms of PD, and found no significant superiority of one 
treatment over another at 8 months after the start of 
treatment. However, so far, no study has compared the 
effectiveness of treatments across widely differing set-
tings and durations. In this article, treatment modality 
was specified as a combination of treatment setting (i.e. 
outpatient, day hospital, or inpatient) and duration (i.e. 
short term or long term), as these are the most important 
aspects regarding treatment costs, a crucial aspect in 
times of restricted health care budgets.
 It is likely that one of the reasons this comparison has 
not been undertaken previously is the difficulty of ran-
dom assignment to different treatment modalities in 
clinical samples due to practical or ethical constraints 
 [19] . Furthermore, even if researchers were successful in 
setting up and starting a randomised treatment modality 
study, its external validity would be doubtful because a 
high number of patients would refuse to participate [e.g. 
 20 ]. Therefore, quasi-experimental studies using statisti-
cal correction models to counter selection bias are in-
creasingly being found in the literature [e.g.  21–24 ].
 The aim of the present quasi-experimental study was 
to compare the effectiveness of different treatment mo-
dalities for patients with cluster C PD in a naturalistic 
setting, thereby insuring high external validity. In fact, 
treatment modality might be an overlooked factor in psy-
chotherapy effectiveness research.
 Methods 
 Participants 
 Participants (n = 371) were recruited from consecutive admis-
sions to 6 mental health care centres in the Netherlands (Centre 
of Psychotherapy De Viersprong, Halsteren; Altrecht, Utrecht; 
Zaans Medical Centre, Zaandam; Centre of Psychotherapy De 
Gelderse Roos, Lunteren; GGZWNB, Bergen op Zoom & Roo-
sendaal; Centre of Psychotherapy Mentrum, Amsterdam). These 
institutions offer outpatient, day hospital, and/or inpatient psy-
chotherapeutic treatment for patients with personality pathology. 
From March 2003 to March 2006, 1,379 patients completed the 
intake procedure and were selected for treatment ( fig. 1 ).
 Of these, 146 patients (10.6%) were excluded from the study for 
not meeting one of the following inclusion criteria: age between 
18 and 70 (n = 13), significant personality pathology (n = 34), and 
referral for psychotherapeutic treatment aimed at personality 
problems (n = 99). Nine patients (0.7%) met one of the following 
exclusion criteria: insufficient command of the Dutch language 
(n = 6), organic cerebral impairment (n = 1), mental retardation 
(n = 1), and schizophrenia (n = 1). This left 1,224 participants, of 
whom 100 (8.2%) refused to participate. Another 31 patients 
(2.5%) could not participate due to logistic reasons (e.g. no ap-
pointment could be made to provide informed consent), and 133 
patients (10.9%) were excluded due to missing or unreliable base-
line data. Thirty-eight patients (3.1%) received less than 2 treat-
ment sessions or less than 2 days of inpatient or day hospital ther-
apy, and were therefore excluded. The remaining 922 patients 
were informed about the study and its procedure, provided writ-
ten informed consent, and entered the study. Of those, 466 pa-
tients (50.5%) had 1 or more cluster C PD.
 In the absence of explicit guidelines for treatment assignment 
in PD  [25, 26] , the selection procedure was based on the expert 
opinion of clinicians who used their clinical experience combined 
with patient data from standardised instruments. To elucidate the 
criteria used for the assignment process, our research group re-
cently conducted a study with intake clinicians from the partici-
pating treatment centres. We found evidence of substantial (im-
plicit) consensus among clinicians concerning the criteria used 
for treatment decision-making. For example, focality of problems 
(focal or broad spectrum of problems) and ego strength were 
found to be related to decisions about a short or long treatment 
duration for a substantial number of intake clinicians  [25] .
 Patients were assigned to 1 of 6 treatment modality groups: 18 
to short-term outpatient (up to 6 months), 96 to long-term outpa-
tient (more than 6 months), 85 to short-term day-hospital, 103 to 
long-term day hospital, 63 to short-term inpatient, and 101 to 
long-term inpatient treatment. The short-term outpatient group 
was excluded from the analyses for 2 reasons: (1) only a minority 
of patients (3.9%) were assigned to this short and low-frequency 
treatment modality, as could be expected in a PD patient popula-
tion; (2) these patients differed significantly from patients in the 
other treatment groups on a high number of pre-treatment vari-
ables, indicating a dissimilar and – most importantly – a structur-
ally less ‘sick’ patient population, incomparable with the rest of 
the sample. A comparison with this treatment modality would 
most probably also fail when trying to design a randomised trial, 
as short-term outpatient therapy differs most from all other mo-
dalities in terms of its relatively low impact on patients’ lives com-
pared to other treatment modalities. In the end, 448 participants 
were included in the study. Follow-up data were not available for 
77 patients (17.2%; patients who did not respond to any follow-up 
assessment or patients where follow-up measurements were not 
yet available). There was no difference in psychiatric symptoms at 
baseline between patients with follow-up data and those without 
(this holds true for both the comparison in the total sample and 
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the comparisons within the 5 treatment groups). The final sample 
consisted of 371 patients to be included in the analyses.
 Treatment 
 The 6 mental health care centres offer a variety of psychother-
apeutic treatments tailored to a PD patient population. Their 
treatments differ according to several features. As this study fo-
cused on different treatment modalities in terms of setting and 
duration, the following 5 treatment groups were compared:
 • Patients in long-term outpatient treatment (n = 68, 18.3% of 
the study sample). These patients come for individual (76.5%) 
or group (23.5%) psychotherapy sessions, for up to 2 sessions 
per week (mean 0.8 sessions/week, SD 0.51, median 0.5) for 
more than 6 months (mean duration 15.4 months, SD 6.36, 
median 12.0). 
 • Patients in short-term day hospital treatment (n = 77; 20.8% of 
the study sample). These patients come to the institutions at 
least 1 morning/afternoon per week (mean 3.2 days/week, SD 
Refused to participate
n = 100
Excluded due to other reasons
n = 164
(logistic reasons n = 31;
missing/unreliable data n = 133)
Assessed for eligibility
n = 1,379
Enrolled
n = 960
Allocated
n = 466
Short
outpatient
treatment
n = 18
Not included
n = 18
Long
outpatient
treatment
n = 96
Short
day hospital
treatment
n = 85
Long
day hospital
treatment
n = 103
Short
inpatient
treatment
n = 63
Long
inpatient
treatment
n = 101
No follow-up
n = 28
No follow-up
n = 8
No follow-up
n = 29
No follow-up
n = 4
No follow-up
n = 8
Analysed
n = 68
Analysed
n = 77
Analysed
n = 74
Analysed
n = 59
Analysed
n = 93
Dropped out prematurely
n = 38
Did not meet inclusion criteria
n = 146
Met exclusion criteria
n = 9
No DSM-IV cluster C
diagnosis
n = 456
 Fig. 1. Patient flow. 
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1.51, median 3.0) for up to 6 months (mean duration 5.4 
months, SD 1.32, median 6.0) and receive different forms of 
psychotherapeutic and psychosocial treatment, but sleep at 
home. 
 • Patients in long-term day-hospital treatment (n = 74, 19.9% of 
the study sample). These patients come to the institutions at 
least 1 morning/afternoon per week (mean 3.3 days/week, SD 
1.42, median 3.0) for more than 6 months (mean duration 12.1 
months, SD 2.41, median 12.0) and receive different forms of 
psychotherapeutic and psychosocial treatment, but sleep at 
home. 
 • Patients in short-term inpatient treatment (n = 59, 15.9% of the 
study sample). These patients stay at the institutions 5 days a 
week for up to 6 months (mean duration 4.2 months, SD 1.48, 
median 3.0) and receive different forms of psychotherapeutic 
and psychosocial treatment. 
 • Patients in long-term inpatient treatment (n = 93, 25.1% of the 
study sample). These patients stay at the institutions 5 days a 
week for more than 6 months (mean duration 10.2 months, SD 
1.98, median 10.0) and receive different forms of psychothera-
peutic and psychosocial treatment. 
 Day hospital and inpatient programs typically consist of group 
psychotherapy as a core element, mostly in combination with one 
or more non-verbal or expressive group therapies, individual psy-
chotherapy, sociotherapy within the therapeutic community, 
coaching for social problems, community meetings, and/or phar-
macological treatment. The psychotherapists are all licensed psy-
chiatrists or psychologists. On average, they had 14.9 years (SD 
10.1) of postgraduate clinical experience. The treatments under 
study can be considered highly representative of regular clinical 
practice in the Netherlands, as therapists did not receive specific 
training for this study and treatment integrity was not moni-
tored.
 Assessments 
 Baseline Measures . An extensive standard assessment battery 
of instruments was administered to the patients before treatment 
assignment. PD were measured using the Dutch version of the 
Structured Interview for DSM-IV Personality  [27, 28] . This inter-
view covers the 11 formal DSM-IV-TR axis II diagnoses including 
PD not otherwise specified, 2 appendix diagnoses (i.e. depressive 
and negativistic PD), and self-defeating PD. Interviewers were 
master’s level psychologists, who were trained thoroughly by one 
of the authors (R.V.), and who received monthly booster sessions 
to avoid deviation from the interviewer guidelines. Inter-rater re-
liability was evaluated in 25 video-taped interviews, which were 
rated by 3 observer-raters. Percentage of agreement between ob-
server-raters ranged from 84 (avoidant PD) to 100% (schizoid) 
(median 95%). Intraclass correlation coefficients for the sum of 
DSM-IV PD traits present (i.e. scores ‘2’ or ‘3’) ranged from 0.60 
(schizotypal) through 0.92 (antisocial) (median 0.74).  To measure 
patient characteristics at baseline, the assessment battery also in-
cluded 3 self-report instruments. The first of those was the Dutch 
version of the Dimensional Assessment of Personality Pathology-
Basic Questionnaire (DAPP-BQ), for measuring the type and de-
gree of personality pathology  [29, 30] . We used patients’ scores on 
this questionnaire for the 4 higher-order factors: emotional dys-
regulation, dissocial behaviour, inhibition, and compulsivity. To 
measure the severity of personality pathology we used the 5 high-
er-order domains of the Severity Indices of Personality Problems 
(SIPP): self-control, social concordance, identity integration, re-
lational capacities, and responsibility  [31] . To measure patients’ 
motivation for treatment, we used the 2 scales of the Motivation 
for Treatment Questionnaire (MTQ-8): need for help and readi-
ness to change  [32] .
 Outcome Measures . The primary outcome measure was gen-
eral psychiatric symptomatology. This was measured using the 
Dutch version of the Brief Symptom Inventory  [33, 34] , a validat-
ed self-report scale derived from the Symptom Checklist 90 – Re-
vised  [35, 36] . In this study, we used the mean score of the 53 items 
of the Brief Symptom Inventory, i.e. the Global Severity Index 
(GSI), ranging from 0 to 4. Psychosocial functioning was mea-
sured with 2 subscales of the Outcome Questionnaire-45 (OQ-
45): (1) interpersonal relations and (2) social role functioning  [37] . 
Health-related quality of life was measured using the EuroQol 
EQ-5D (EQ-5D)  [38] . All 4 outcome measures, the GSI, OQ-45 
interpersonal relations, OQ-45 social role, and EQ-5D, were as-
sessed at baseline and several follow-up points. Three treatment 
centres conducted their follow-up at approximately 12, 24, and 36 
months after baseline; the other 3 treatment centres conducted 
their follow-up at the end of treatment, approximately 6 and 12 
months afterwards, and again at 36 months after baseline. The 
use of different assessment points was due to logistic reasons, and 
was taken into account by choosing multilevel modelling as the 
statistical method for the analyses.
 Statistical Analyses  
 We first examined the uncorrected results on all 4 outcome 
measures at 12 months after baseline. We used multilevel model-
ling to deal with: (1) the dependency of repeated measures on the 
same subject in time and (2) longitudinal data with observations 
unequally spaced in time (see ‘Outcome measures’). To estimate 
the uncorrected treatment effect at 12 months after baseline, we 
used a random intercept and random slope model with time as 
level I and patient number as level II. This resulted in a final best-
fitting model with the following independent variables: dummy 
variables indicating group membership, time, and interaction be-
tween group membership and time. Subsequently, we calculated 
within-group effect sizes (Cohen’s d)  [39] to describe change from 
baseline to 12 months in each group.
 However, since this is a non-randomised study, the compari-
son of the groups had to be corrected for the influence of con-
founders, i.e. initial patient differences. To adjust for these differ-
ences and avoid bias in effect estimation, we included a ‘multiple 
propensity score’ in our analyses. The classic propensity score is 
defined as the conditional probability of assignment to 1 of 2 
treatment groups given a set of observed pre-treatment variables 
 [40] . The multiple propensity score is an extension of the classic 
propensity score to more than 2 treatment groups  [42] . Statistical 
inclusion of possible confounders in the outcome analyses con-
trols selection bias due to known confounders while comparing 
multiple groups. To identify relevant confounders, we considered 
a long list of social, economic, and diagnostic variables carefully 
selected by both clinicians and researchers, based on the literature 
and clinical knowledge  [43] . All variables significantly related to 
a specific outcome were used to estimate the multiple propensity 
scores in a multinomial regression analysis, with group member-
ship as a dependent variable (see  table 1 for the variables included 
in the GSI propensity score; complete list of potential/identified 
confounders for all outcome variables available upon request). 
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One major advantage of the propensity score method, as com-
pared to other correction techniques, is the fact that the overlap 
in propensity score distributions (and thus the overlap in relevant 
variables) between treatment groups can be easily judged and vi-
sualised. From looking at the overlap between the 5 treatment 
groups, it appeared that in spite of some differences these groups 
were readily comparable. For a detailed description of this meth-
od and its use in psychotherapy research, see Bartak et al.  [43] .
 A more sophisticated multilevel model, now including multi-
ple propensity scores, was used to compare change in outcome 
variables across treatment groups. Dependent variables were the 
change scores (from baseline) observed during follow-up for each 
of the outcome measures. Independent variables were dummy 
variables indicating group membership, time, interaction be-
tween group membership and time, and the multiple propensity 
scores (with their mutual interactions). This model estimated dif-
ferences in change scores at 12 months after baseline in pairwise 
comparisons of the 5 treatment groups. If significant differences 
in change scores were found, we calculated between-group effect 
sizes.
 To render the outcome estimates at 12 months more reliable, 
we made optimum use of the potential of our data-set by includ-
ing all available data collected up to 800 days after baseline. Data 
collected after that point was not used in order to prevent bias of 
the 12-month data due to changes much later in the process. The 
number of available follow-up measures was as follows: up to 800 
days, 30.5% of the total sample had 1 follow-up measure, 36.7% 
had 2 follow-up measures, and 32.9% had 3 follow-up measures. 
The analyses were performed using SPSS 15.0 for data preparation 
and Proc Mixed of SAS 9.1.3 for multilevel modelling (SAS Insti-
tute, Cary, N.C., USA).
 Results 
 Sample Characteristics 
 Of the 371 patients, 29.6% were male and 70.4% were 
female. The mean age was 33.5 years (SD 9.5). The highest 
level of education was low for 22.9%, medium for 19.4%, 
and high for 57.7%. Furthermore, 70.4% were unmarried, 
21.3% were married, and 8.4% were divorced or widowed. 
The majority, 66.6%, had ‘pure’ cluster C PD (i.e. no co-
morbid cluster A or B PD), 23.7% had a combination of 
cluster C PD and cluster B PD, 4.0% had a combination 
of cluster C PD and cluster A PD, and 5.7% had a combi-
nation of cluster C PD and both cluster A and B PD. A 
majority (63.3%) had a diagnosis of avoidant PD, 49.3% 
had a diagnosis of obsessive-compulsive PD, and 22.6% a 
diagnosis of dependent PD.
 Uncorrected Outcome 
 One year after baseline, patients in all treatment 
groups showed improvement in terms of psychiatric 
symptoms (GSI), the primary outcome measure. This is 
shown in  table 2 and  figure 2 . Within-group effect sizes 
Table 1. Variables used for propensity score estimation, outcome 
GSI
Variable Content
Age patient’s age
DAPP-BQ Emotional
dysregulation
unstable affective responding,
interpersonal problems
DAPP-BQ Inhibition deriving little enjoyment from intimate 
relationships
MTQ-8 Need
for help
patient’s expressed desire for external 
help
MTQ-8 Readiness
to change
willingness for treatment-seeking
behaviour
EQ-5D quality of life
SIPP Self-control capacity to tolerate, use and control one’s 
own emotions and impulses
SIPP Identity
integration
coherence of identity; the ability to see 
oneself and one’s own life as stable, 
 integrated and purposive
SIPP Relational
capacities
capacity to genuinely care about others
as well as feeling cared for by them,
to be able to communicate personal 
 experiences, and to hear and engage with 
the experiences of others often but not 
necessarily in the context of a long-term 
intimate relationship
SIPP
Responsibility
capacity to set realistic goals, and to 
achieve these goals in line with the 
 expectations generated in others
GSI level of psychiatric symptoms
OQ-45 Symptom
distress
level of symptom distress
OQ-45 Relational
functioning
level of interpersonal functioning
OQ-45 Social role
functioning
level of social and work functioning
Dimensional score
cluster C PD
dimensional score of cluster C PD
characteristics
Total dimensional
score all PD
dimensional score of all PD
characteristics
Avoidant PD diagnosis of avoidant PD
Dependent PD diagnosis of dependent PD
Obsessive-
compulsive PD
diagnosis of obsessive-compulsive PD
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of the uncorrected scores ranged from 0.62 (medium ef-
fect, short-term day hospital group) to 1.78 (huge effect, 
short-term inpatient group).
 Improvements were also seen in terms of psychosocial 
functioning and quality of life ( table 2 ). Effect sizes for 
these outcome measures were somewhat lower compared 
to psychiatric symptoms, but a positive change in psycho-
social functioning and quality of life was evident.
 Corrected Comparison 
 After correction for all relevant pre-treatment differ-
ences, improvement between baseline and assessment at 
12 months proved to be significant for patients in all 
treatment groups on all 4 outcome measures (p  ! 0.001). 
 The short-term inpatient group showed significantly 
more improvement in psychiatric symptoms (GSI) than 
3 other groups: the short-term day hospital group (  = 
0
1
2
3
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 Fig. 2. GSI uncorrected mean scores at 
baseline and 12-month follow-up. 
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Table 2. Uncorrected outcomes (mean 8 SD) and effect sizes in 5 treatment groups for all outcome variables
Variable Treatment group Baseline 12 months Within-group effect
size, Cohen’s d
GSI long, outpatient (n = 68) 1.4980.69 1.0780.65 0.63
short, day hospital (n = 77) 1.4480.63 1.0480.67 0.62
long, day hospital (n = 74) 1.6880.61 1.1280.94 0.71
short, inpatient (n = 59) 1.7580.52 0.7680.60 1.78
long, inpatient (n = 93) 1.7780.72 1.0380.68 1.06
OQ-45 long, outpatient (n = 68) 15.8484.27 12.9884.42 0.66
Social role short, day hospital (n = 77) 15.2084.52 13.5984.53 0.36
long, day hospital (n = 74) 16.7984.75 13.3985.29 0.68
short, inpatient (n = 59) 17.7883.84 12.4184.83 1.24
long, inpatient (n = 93) 16.9784.64 12.4285.31 0.92
OQ-45 long, outpatient (n = 68) 22.2285.98 19.3786.43 0.46
Interpersonal short, day hospital (n = 77) 20.9385.24 18.1785.90 0.50
relations long, day hospital (n = 74) 22.8986.41 18.4188.05 0.62
short, inpatient (n = 59) 23.9785.63 17.5486.77 1.04
long, inpatient (n = 93) 24.0985.24 18.3886.59 0.96
EQ-5D long, outpatient (n = 68) 0.5880.24 0.7380.16 0.74
short, day hospital (n = 77) 0.6080.25 0.6980.24 0.37
long, day hospital (n = 74) 0.5080.27 0.7280.22) 0.90
short, inpatient (n = 59) 0.4980.27 0.7880.21 1.21
long, inpatient (n = 93) 0.5180.26 0.6880.25 0.67
 Bartak et al. Psychother Psychosom 2010;79:20–3026
0.38, p = 0.0059, 95% CI 0.11–0.65), the long-term day-
hospital group (  = 0.43, p = 0.0032, 95% CI 0.15–0.71), 
and the long-term inpatient group (  = 0.31, p = 0.0248, 
95% CI 0.04–0.57) ( table 3 ). Between-group effect sizes 
(Cohen’s d) were 0.54, 0.57, and 0.40, respectively. This 
indicates medium effect sizes for the between-group 
comparisons of short-term inpatient treatment versus 
other treatment groups.
 In terms of social role functioning, the short-term in-
patient group improved significantly more than 2 other 
groups – the short-term day hospital group (  = 2.51, p = 
0.0067, 95% CI 0.71–4.31) and the long-term day hospital 
group (  = 2.05, p = 0.0476, 95% CI 0.02–4.07) – with be-
tween-group effect sizes of 0.49 and 0.38, respectively. 
The improvement in interpersonal functioning was sig-
nificantly higher in the short-term inpatient group than 
in one other group – the short-term day hospital group 
(  = 2.54, p = 0.0319, 95% CI 0.22–4.86) – with a between-
group effect size of 0.39. Quality of life improved signifi-
cantly more in the short-term inpatient group than in 2 
other groups: the short-term day-hospital group (  = 
0.15, p = 0.0009, 95% CI 0.06–0.23) and the long-term in-
patient group (  = 0.11, p = 0.0113, 95% CI 0.03–0.19). 
Between-group effect sizes were 0.6 and 0.42, respec-
tively.
 All results were based on intention-to-treat analyses 
(ITT), whereby ITT is defined as assignment and a min-
imal exposure to the intended treatment modality. The 
analyses  were  repeated  with  the treatment completers, 
i.e. those who actually stayed in the intended treatment 
modality group during their treatment (n = 298, 80.3% of 
the ITT sample, ranging from 66.2% for short-term day 
hospital to 89.7% for long-term outpatient treatment). 
These results followed the same pattern as the results 
from the ITT analyses: significant change within all 
treatment groups and a superiority of short-term inpa-
tient treatment across all outcome measures (data avail-
able on request).
Table 3. Difference scores () of 5 treatment groups 12 months after baseline, corrected for propensity score (all outcome variables)
Variable Treatment group n 
long, outpatient short, day hospital long, day hospital short, inpatient
GSI long, outpatient
short, day hospital
long, day hospital
68
77
74
–0.078
–0.128 –0.050
short, inpatient 59 0.302 0.380** 0.430**
long, inpatient 93 –0.004 0.075 0.124 –0.306*
OQ-45
Social role
long, outpatient
short, day hospital
long, day hospital
68
77
74
–1.632
–1.123 0.460
short, inpatient 59 0.876 2.508** 2.048*
long, inpatient 93 –0.169 1.463 1.003 –1.045
OQ-45
Interpersonal
relations
long, outpatient
short, day hospital
long, day hospital
68
77
74
–0.836
–0.611 0.225
short, inpatient 59 1.704 2.540* 2.315
long, inpatient 93 –0.084 0.752 0.527 –1.788
EQ-5D long, outpatient
short, day hospital
long, day hospital
68
77
74
–0.060
0.001 0.061
short, inpatient 59 0.089 0.149*** 0.088
long, inpatient 93 –0.021 0.039 –0.022 –0.110*
Positive coefficients indicate that the treatment group shown in the left column is superior, negative coefficients indicate that the 
treatment group in the above row is superior. * p < 0.05, ** p < 0.01, *** p < 0.001.
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 Discussion 
 This is the first study comparing the effectiveness of 5 
modalities of psychotherapeutic treatment in a large pop-
ulation of patients with cluster C PD, as a contribution to 
the search for effective treatments for this patient group. 
Patients in all treatment groups had improved psychiatric 
symptoms, psychosocial functioning, and quality of life 
after 12 months. Most improvement was observed in the 
short-term inpatient group. This finding held when pre-
treatment differences were controlled for with the pro-
pensity score.
 Strengths and Limitations 
 A clear strength of the present study is its external va-
lidity and clinical utility: it was conducted in regular clin-
ical practice, not under experimental conditions  [44] . A 
second strength is the rigorous statistical control of po-
tential confounders, using the multiple propensity score 
methodology. Finally, a major asset of this study is its 
large number of patients. All this enabled the compari-
son of  different psychotherapeutic treatment modalities 
while keeping sufficient statistical power.
 Despite these strengths, the present findings have to 
be interpreted considering several limitations. First, even 
though we controlled for all observed pre-treatment dif-
ferences, it cannot be ruled out that results have been 
influenced by unobserved confounders. To diminish 
this constraint as much as possible, a broad range of pos-
sible confounders was carefully selected and measured, 
based on both clinical and empirical knowledge  [43] , in-
cluding variables identified in the literature as signifi-
cant predictors of therapy outcome or process, such as 
severity of baseline psychopathology, previous hospitali-
sation, and substance misuse [e.g.  45–50 ]. In line with 
these earlier findings, previous hospitalisation and sub-
stance misuse for example were significantly related to 
one of the secondary outcome measures, interpersonal 
functioning, and were therefore included in the propen-
sity score for this measure. However, even when consid-
erably reducing the possibility of important confounders 
being overlooked, not all possible variables could be cov-
ered in interviews and questionnaires at baseline, and 
therefore several variables, such as self-harm  [51] , were 
not measured.
 Second, for ethical reasons, a control group receiving 
no treatment at all was not included. Yet, several previous 
studies showed that specialised psychotherapeutic treat-
ment yields better outcomes than various control condi-
tions (for example waiting list controls)  [8, 9, 13] .
 Third, research compliance differed between the treat-
ment groups compared with most missing follow-up ob-
servations in the long-term treatment groups ( fig. 1 ). This 
might cause a problem of internal validity if non-response 
is not random, but related to systematic bias in effect es-
timation (positive or negative). However, there are 2 rea-
sons why systematic bias seems unlikely: (1) responders 
and non-responders did not differ in psychiatric symp-
toms at baseline, and therefore it seems that they do not 
represent 2 structurally different groups of patients; (2) 
during the frequent telephone contact the authors had 
with non-responding patients to remind them to send 
back their questionnaires, these patients reported both 
negative and positive outcomes as reasons why they did 
not respond: some of them argued that their problems 
had worsened and that therefore they felt they did not 
have enough energy to fill in the questionnaires, others 
argued that their life had changed in a positive way and 
that therefore they did not want to be reminded of their 
time in therapy by filling in the questionnaires. Keeping 
this in mind, it seems unlikely that non-response was re-
lated to systematic negative or positive bias.
 Fourth, this study does not rule out the possibility that 
treatment characteristics other than setting and duration 
played a role in the differential effectiveness of the 5 treat-
ment modalities, e.g. frequency of sessions or theoretical 
orientation of treatment. This might represent a potential 
threat to internal validity. This is especially true for the 
role of theoretical orientation as a possible factor in the 
superiority of short-term inpatient treatment: most short-
term inpatient programs were based on psychodynamic 
principles. This concern is somewhat mitigated by previ-
ous studies comparing different theoretical orientations 
where no differences were found [e.g.  12 ]. However, to test 
the differential effect of modality and other treatment 
characteristics, a combined research design combining 
all these factors is needed.
 Future Directions and Implications 
 What are the implications of the present results for fu-
ture research, for practice guidelines, and for everyday 
clinical practice?
 For patients with cluster C personality pathology, 
short-term inpatient treatment clearly was associated 
with the highest improvement within 12 months. For this 
patient group, this modality of therapy seems to be the 
treatment backed up by the best available evidence – in 
absence of long-term follow-up data. Replication of these 
results in a long(er)-term follow-up study is of vital im-
portance to draw final conclusions. There might be a bias 
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in favour of short-term treatment because patients in the 
long-term treatment groups might still be in therapy at 
12 months. Long-term follow-up after termination of all 
treatment programs is therefore warranted. Another 
question is whether the benefit in terms of effectiveness 
is worth the potential cost differences when evaluated 
with recently upcoming state-of-the-art cost-effective-
ness analyses [e.g.  52, 53 ]. From these analyses within our 
study sample, it appeared that the mean direct treatment 
costs of the 5 treatment modalities were EUR 10,005 (SE 
1,134) for long-term outpatient treatment, EUR 16,813 
(SE 1,361) for short-term day hospital treatment, EUR 
27,648 (SE 2,654) for long-term day hospital treatment, 
EUR 25,933 (SE 859) for short-term inpatient treatment, 
and EUR 49,260 (SE 2,435) for long-term inpatient treat-
ment  [Soeteman,  unpubl.  data].  It would be interesting 
to compare the cost-effectiveness of short-term inpatient 
psychotherapeutic treatment with that of manual-based 
outpatient treatments, such as cognitive-behavioural 
therapy  [9] . A state-of-the-art cost-effectiveness analysis 
would include medical costs incurred outside the treat-
ment institution, productivity costs, and other indirect 
costs. This kind of analysis and its economic interpreta-
tion is beyond the range of this study and needs consider-
able research in the future.
 If the superiority of short-term inpatient psychothera-
peutic treatment holds at long-term follow-up, in cost-
effectiveness analyses, and in comparison with other evi-
dence-based manual-based treatments, this treatment 
modality might be considered as the treatment of choice 
for this patient group. This would be a thought-provok-
ing finding, as previous studies in cluster B PD patients 
have found outpatient  [54–56] and day hospital  [57] treat-
ments to be very effective in this population. Even though 
no study compared one of these modalities directly with 
inpatient therapy, one might speculate that different ther-
apy modalities are effective for different groups of pa-
tients. It could be that the success of short-term inpatient 
treatment in a cluster C PD sample is embedded in the 
combination of only short hospitalisation – thereby pre-
venting iatrogenic effects – and a high level of therapeutic 
intensity and pressure. Patients with cluster C personal-
ity pathology might be able to handle the high pressure 
of this treatment modality better than (pure) cluster B PD 
patients, who probably have a lower tolerance for thera-
peutic pressure, resulting in more early dropouts and 
thus a less effective treatment. They might instead need 
less pressure with a longer treatment duration  [57, 58] . 
Future studies may verify this hypothesis. However, even 
when superiority of short-term inpatient treatment for 
cluster C PD patients has been confirmed in the litera-
ture, patients caring for children might still not be as-
signed to inpatient treatment. Also, patients with a high 
severity of psychiatric symptoms or a low level of ego 
strength might not be able to handle the pressure of in-
tensive inpatient treatment. It is recommended to inves-
tigate these potential matching factors further as this 
would enable clinicians to make specific treatment rec-
ommendations for different subgroups of cluster C PD 
patients and to develop new clinical practice guidelines.
 In conclusion, this study suggests that psychotherapy, 
especially in a short-term inpatient modality, is an effec-
tive treatment for patients with cluster C PD. This makes 
inpatient psychotherapeutic treatment an interesting op-
tion for patients with avoidant, dependent, and obsessive-
compulsive PD. The present findings can contribute to 
more adequate and tailored health care for this vulnera-
ble patient group, as implementing effective treatments 
may reduce the considerable burden to individuals and 
society as a whole.
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